chapter twenty two

22 Healthcare supply chain powered by SSI

 

by Daniel Fritz and Marco Cuomo

For many industries, tracking and monitoring movement of goods in global supply chains is a key priority, sometimes even a regulatory requirement. Daniel Fritz and Marco Cuomo, innovation leaders at the Swiss-based pharmaceutical company Novartis, outline how their industry’s supply chain could be transformed—and how this can inspire other supply chain business leaders around the world to use self-sovereign identity (SSI) technologies.

Доверяй, но проверяй

Trust, but verify.” - Russian proverb adopted by president Ronald Reagan in nuclear disarmament treaty negotiations with the Soviet Union.

SSI will transform how supply chains operate—it is not a question of if, but when. A common, trusted, privacy-preserving approach for product and customer identification and transactions will reduce complexity, cost, and time. When broadly adopted, SSI will enable new business models for value-adding participants, resulting in benefits for local communities and the environment. Trusted end-to-end transparency for a supply chain is a good thing when considering a single industry. When several industries are transformed by SSI, the impact is not just good—it can be a paradigm shift that can accelerate an industrial revolution. 

22.1  Emma’s story

22.2  Supply chain transparency and efficiency through SSI

22.3  Industry ecosystem efficiency powered by SSI

22.4  Future supply chain transformation across industries—the big picture

22.5  Elimination of waste

22.5.1    Authentication and quality

22.6  Summary

22.7  SSI Scorecard for Pharma Supply Chain